Biosimilar Newsletter Archive

51. 02.03.22 -- Congressional Bill Bolsters Continuous Manufacturing 2/3/2022
    02/03/22 Biosimilar Development Newsletter
52. 01.31.22 -- Managing The Biomanufacturing Supply Chain 1/31/2022

    01/31/22 Biosimilar Development Newsletter

53. 01.28.22 -- Enabling An Improved Patient Experience Through Innovative Solutions 1/28/2022

    01/28/22 Biosimilar Development Newsletter

54. 01.27.22 -- 2021's Bioprocessing Year In Review 1/27/2022
    01/27/22 Biosimilar Development Newsletter
55. 01.20.22 -- Data Integrity: New & Pending Guidances 1/20/2022
    01/20/22 Biosimilar Development Newsletter
56. 01.19.22 -- Bioprocess Automation To Help Enhance Efficiency And Operations 1/19/2022

    01/19/22 Biosimilar Development Newsletter

57. 01.13.22 -- Listen Now: CAR T Manufacturing Control, Genome Engineering of Hematopoietic Stem Cells, and more! 1/13/2022
    01/13/22 Biosimilar Development Newsletter
58. 01.13.22 -- How EU Biopharma Can Blaze The IDMP Data Standards Trail 1/13/2022
    01/13/22 Biosimilar Development Newsletter
59. 01.06.22 -- Bioprocess Facility Design: Layout Rules & Configurations 1/6/2022
    01/06/22 Biosimilar Development Newsletter
60. 12.23.21 -- Regulatory Intelligence: It's More Than Just Compliance 12/23/2021
    12/23/21 Biosimilar Development Newsletter